Pasvolsky, O., Abid, M. B., Milton, D., Tanner, M., Bashir, Q., Srour, S., Saini, N., Lin, P., Ramdial, J., Nieto, Y., Tang, G., Haider, A., Aljawai, Y., Kebriaei, P., Gaballa, M., Patel, K., Ye, J. C., Thomas, S., Orlowski, R., Champlin, R., Shpall, E., Qazilbash, M. (2025). Daratumumab, bortezomib, lenalidomide and dexamethasone, upfront autologous transplant and lenalidomide maintenance for newly diagnosed multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-7509